Abstract：Objective To analyze the therapeutic effect of ipratropium bromide combined with ceftazidime on chronic obstructive pneumonia. Methods A total of 92 patients with chronic obstructive pneumonia were selected as the study subjects.They were divided into control group and observation group by random number table method,with 46 cases in each group.Both groups received conventional treatment.On this basis,the control group was treated with ceftazidime for injection,and the observation group was treated with ipratropium bromide inhalation aerosol combined with ceftazidime for injection.Both groups were treated for 2 weeks.The levels of inflammatory indicators（IL-6,TNF-α,CRP）and pulmonary function indicators（FEV1/FVC,MMEF,PEF）before treatment and 2 weeks after treatment were compared between the two groups,and the incidence of adverse reactions during treatment was recorded. Results After 2 weeks of treatment,the levels of serum IL-6,TNF-α and CRP in the two groups were lower than those before treatment,and the observation group was lower than the control group,the difference was statistically significant（P<0.05）.After 2 weeks of treatment,the levels of FEV1/FVC,MMEF and PEF in the two groups were higher than those before treatment,and the observation group was higher than the control group,and the difference was statistically significant（P<0.05）.During the treatment period,there was no statistically significant difference in the incidence of adverse reactions between the two groups（P<0.05）. Conclusion Ipratropium bromide combined with ceftazidime in the treatment of chronic obstructive pneumonia can effectively reduce the degree of inflammation in the body and improve lung function.
张瑞梅, 李铭铭, 马凯月. 异丙托溴铵联合头孢他啶治疗慢性阻塞性肺炎的疗效[J]. 哈尔滨医药, 2022, 42(5): 16-18.
Zhang Ruimei, Li Mingming, Ma Kaiyue. Efficacy of Ipratropium Bromide Combined with Ceftazidime in the Treatment of Chronic Obstructive Pneumonia. journal1, 2022, 42(5): 16-18.
2022, Vol. 42 
